Abstract
BackgroundMonoclonal antibodies inhibiting tumour necrosis factor-α (TNFα) signalling pathway (anti-TNFα) have been widely used in Crohn’s disease (CD). However, treatment response varies among patients with CD and the clinical outcome...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have